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Thenatureofboth indoorairexposuresandnoncancerend pointspresent nt issuesforriskcharacterization.
Noncancer end pointsaremultidimensional, affectingvariousorgans, andareassmed tohavetrsholds. Symptoms
also vary inseverity within apopulation. Inaddtiontothecompexkityof n risk at, indoor irexposures
are typified by the presence of complex mixtures, which furtber complictes the compex nature of noncancer risk
characterization. Mostnoncancerriskasssmenteffortshavefocusedondefaingacceptabledaiyintakesorreference
doses (RfD)ratherthanestimatingincidenceandseverityofthewidenngeofefectswitnaneposedpotion. The
riskcharacterizationfrnaework hasbeendeveloped toacmmodatetheRIDapproachbut, moreimportantly, toad-
dressthemultidimensionalnatureofnoncancerriskcharacteriation.NewlyemergingmethodsandstandardEPArisk
assessment guidelinesfornoncancereffectsandcomplxmixtureswereusedasguidesfordhopngthefraework. In-
formationanddataneedshavebeenidentifiedfromtheframework. Peak, average, andcumulative dosesfrom indoor
airexposuresare highlydependentonvariableindoorairconcentrationsandaffectedbytime-activity patterns. Suscep-
tibilityalsoplaysasignificantroleinnoncancerendpointsand,unlikesusceptibility incancerrisk at,isquan-
tifable. his paper jlihtstheriskcharacterizationfrmeworkfornocancerheathriskstatwede oloped incoopera-
tion with the U.S Environmental Protection Agency Environmental Criteria and n t Office. Additionally, a
preliminary applicationofthe framework toacomplex mixtureofvolatileorganic compounds from indoor sources is
illustrated.
Introduction
TheResearchTriangleInstitute(RTI), incooperationwiththe
U.S. Environmental Criteriaand AssessmentOffice, Research
TrianglePark(ECAO-RTP), hasdeveloped ariskcharacteriza-
tion framework toprovide asystematicapproach foranalyzing
andpresenting studyresultsthatestimatethehealthrisksforin-
doorairpollutants. The framework was initially developed for
characterizing both carcinogenic and noncarcinogenic health
risks. However, due to several substantive differences between
these typesofhealth risks, two separate frameworks havebeen
developed. This paperpresentstheriskcharacterization frame-
workfor noncancerhealthrisksand apreliminaryapplicationof
the framework to a complex mixture ofvolatile organic com-
pounds from indoor sources.
Noncancer RiskCharacterization
Framework
Theriskcharacterization frameworkfor noncancerhealthef-
fects ispresented inFigure 1. Itprovides a means todisplay the
complexity ofcharacterizing noncancerhealtheffects, theissues
involved, the data and information needs, and the relationship
amongthesedataelementsandissues. Thefourelementsofrisk
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assessment, hazard identification, exposureassessment, dose-
response assessment, andriskcharacterization, arerepresented
intheframework. Theriskassessmentprocessasrepresentedin
the framework is further subdivided into 10 elements (re-
presentedbycolumnsBthroughKinFigure 1). Thisallows for
greaterdetail inexamining theoverall risk estimation process.
HazardidentificationiscoveredincolumnsBthroughJofFigure
1 in a primarily qualitative manner; exposure assessment is
coveredbycolumnsBthroughF, dose-responseassessmentby
columnsGandH,andriskcharacterizationbycolumnsIthrough
K, though it actually integrates information from all previous
steps. Theframeworkhasbeensubdividedintothefourgroup-
ingsatthetopofthefiguretoexhibitdataneedsforcharacterizing
exposure(columnsC-E),dose(columnsE-G), individualhealth
effects (columns G-1) and population health effects (columns
I-K).
The major elements ofnoncancer risk characterization are
outlined and summarized below. The concepts and issues
presentedrepresenttheidealintermsoftheinformationanddata
neededtoconductathoroughriskcharacterizationofnoncancer
health effects. The issues and data needs presented in the
frameworkincludebothstandard EPAmethods (fornoncancer
and complex mixture risk assessment) and state-of-the-art,
emergingtechniques. Typically, dataareunavailable tousethe
sophisticatedemergingmewhods, andsuandardEPAmethodsare
relied upon. However, the ideal information needs have been
presented to fully elucidate the dimensions ofnoncancer riskPIERSON ETAL.
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FIGURE 1. Riskcharacterization framework fornoncancerhealtheffects. Note
thatcolumnAhasbeen intentionallyomittedas it isnotrelevanttothispaper.
characterization. Asthemajorissues relatedtononcancerhealth
effects is the nature ofthe effects themselves, discussion ofthe
frameworkwill startwiththegoalsoftheriskcharacterization,
how individualandpopulationhealtheffects aredescribed (col-
umns I-KofFigure 1). Discussion will then focuson the other
columns in order (columns C-H) and how the nature of non-
cancer health effects influences these components.
Risk Characterization
Characterization ofnoncancer health effects differs (colums
l-KofFigure 1) from those ofcancer in the breadth ofeffects
coveredand inthedetail inwhichtheyarecharacterized. Cancer
risksaretypically characterizedasthenumberofcasesofcancer
attributed totheexposure in question. However, noncanceref-
fectsconsistofmultiple endpointseachhaving varyingdegrees
ofseverity. Additionally, not all individuals may be at risk, or
specific varying susceptibilities may existwithin apopulation.
Riskfornoncancereffectsideally wouldbeexpressedasdistribu-
tions within a population by effect and severity rather than a
single estimate ofincreased cases.
Individual Health Effects
Thefirstimportant factorincharacterizing noncancerrisksis
thenatureofthehealtheffects (columnIinFigure 1). Oneofthe
major differences between cancer and noncancer effects is the
concept of threshold. Most, if not all, noncancer effects are
assumed to have athreshold below which no adverse health ef-
fect would result from exposure. By contrast, cancereffects are
assumed to have nothreshold, with any exposure adding to the
excess individual risk. Coupled tothresholds is thequestion as
towhatconstitutes an "adversehealtheffect." Effectscanrange
in severity fromametabolic change with noobservedchangein
theperformance ofthe individual to (frank) clinical conditions
and illness todeath. Theframeworkcanpresentthewide range
ofeffectspredicted, including adverseeffects as well aspossible
biological indicatorsoffutureeffectsorincreasedsusceptibilities
to other or later exposures.
Anothercharacteristicofnoncancerhealtheffects isthatmulti-
ple target organs and systems can beaffected with awide range
ofreported symptoms, effects, andseverity. Althoughthere are
many types ofcancer, cancer effects aredefined asthepresence
orabsenceofcancer. Bycontrast, noncancereffectsvarygreatly
and may include diverseeffects or symptoms.
This complexity incharacterizing noncancer health effects is
exemplifiedbyaconditionassociatedwithindoorairexposures,
sick-building syndrome (SBS). SBS has become a relatively
common problem attributed to volatile organic compounds
(VOCs), biological contaminants, and other pollutants, con-
sisting ofacute, nonspecific sensory irritation andothersensory
effects. TheWorld HealthOrganization(1) defined SBS symp-
toms to includea)eye, nose, andthroatirritation, b) sensation
ofdry mucous membranes, c) erythema (skin irritation, red-
ness), d)mentalfatigueandheadaches, e)highfrequency ofair-
wayinfectionsandcough,J)hoarsenessandwheezing,g)itching
andunspecifichypersensitivity, andh)nauseaanddizziness. The
varietyofendpointsisapparent inthiscondition, affecting multi-
pleorgans (eye, respiratory, etc.) withvarying severity (eye ir-
ritation tounspecific hypersensitivity).
There aretemporalconsiderations inaddition tothe factthat
therearemultipleorgans andeffects. Cancereffectsaretypically
removedfromexposures bylatency periods associated with the
mechanisms ofcancer, andtherefore, cancer risks aredefinedon
thebasisofincreased statistical probabilityofdeveloping cancer.
By contrast, for noncancer health effects, timetoappearanceof
theeffectandwhetherornottheeffectisreversibleorpermanent
areimportant. Effectsmaybeimmediateandtieddirectly toex-
posure, suchasirritation, ormaybedelayed inappearance as in
developmental orreproductive effects. Additionally, effects may
be transient, such as irritation, or permanent, as in unspecific
hypersensitivity.
Thepredictionoftheincidenceormanifestationofeffectis not
thefinalestimatorofriskasincancer. Theseverityoftheeffect,
both in termsofintensity ofresponse and inthreattothehealth
oftheoverallorganism isequally important. Severity asathreat
to the whole organism is not amenable to direct quantitative
measurement (2), though ordinal ranking schemes have been
proposedtoassess severity. Tallaridaetal. (3)developedarank-
ingschemebasedonarisk/benefitanalysisofadversedrug reac-
tionstodevelop ordinal rankingsofdisease states. Hartung and
Durkin (2) have expanded onthis concept by dividing severity
ranking into two components, an empirical severity rating and
a subjective severity ranking.
Typically, noncancer effects are not life threatening but are
believed toaffecttheperformance ofan individual. Therefore,
some measureofimpaired function isdesirable. These subjec-
tiveratingvaluescanbedevelopedbypollsandarelikelytohave
greatvariationamong individuals butmayproveuseful inquan-
tifying function impairmentofindividual performance. Ideally,
all values for adverse health effects presented in column I of
Figure 1 shouldbeforastandard individual (e.g., asensitive in-
dividual, or a lower 10th or upper 95th percentile within the
population) foreachorganaffectedandincludeameasureofthe
intensity for each effect. These values can then be used as a
benchmark to calculate population effects. This information
would be presented for each pollutant being evaluated and, if
possible, forthe overall mixture.
Affected Population
Individual responses varygreatly within apopulation (column
JofFigure 1). The susceptibility ofan individual to a specific
Q. z^ w. 74W; 147
122
1Inc,denceRISK CHARACTERIZATION OF NONCANCER END POINTS
adverse effect dictates the level of a response. Individual
susceptibilities are believed to follow some statistical distribu-
tion within a population. Additionally, susceptibility may be
rooted in personal behavior, activities, and exposures
associated with those activities. Individual sensitivities are
distributed among a population and can include sensitive sub-
populations (e.g., children in the case of low-level lead ex-
posure), genetic predispositions (e.g., enzyme deficiencies),
other exposures (e.g., smoking), preexisting conditions (e.g.,
asthma), and illness.
It is desirable to characterize exposed populations in column
Jonthebasisoftheirsensitivities. Thisisaboveandbeyondwhat
is typically done for cancer risk assessment. Calculation of
populationriskswould, therefore, havetocorrelateinformation
onspecificsusceptibility anddisease. Theprevalenceofspecific
susceptibilities within apopulation would identify the affected
portionoftheexposedpopulationandwouldbepresented incol-
umnJ. Informationpresented inthiscolumnwouldincludethe
distribution ofgeneral susceptibility foreach effect.
Population Health Effects
Populationriskestimates wouldbepresented incolumnKof
Figure 1 as the distribution ofeffects and severity within the
population. Population incidenceestimates arederived from in-
dividual responsedata, informationonthedistributionofsuscep-
tibility, and data on specific susceptibilities.
Exposure Assessment
Noncancereffectsaregenerallytiedmoredirectlytoactualex-
posurepatternsandtheassociated dosethanarecancereffects.
As a result, greater detail is desirable for the exposure assess-
ment. Thedetails neededforconducting exposureassessments
ofnoncarcinogens arediscussedbelowandfollowtheorganiza-
tionofthecolumns ofthe framework shown in Figure 1.
PollutantConcentration. Someindoorairpollutant sources
areconstant, resulting inanequilibriumwithregardtopollution
concentrations (column CofFigure 1). In such cases, a single
valueforpollutantconcentration, deterninedby directmeasure-
ment or estimated from models, can be used to calculate ex-
posure. However, most indoor airpollutantconcentrations are
transitoryorepisodic andaredependentonthepollutantsource,
its use and environmental and building conditions. Indoor air
concentrationsduetoanindividual sourceoractivity(use)would
tendtofollowoneofthegeneralprofiles shown inFigure2. The
actual shapeofthe decay curve is dependent on emission rate,
temperature, humidity, andventilation. Thedurationofthepro-
filemayvarygreatly fromseveraldaysorweeks (e.g., carpetin-
stallationorotherbuildingrenovations) tominutes(e.g., useof
householdproducts). Theoverallconcentrationprofilewouldbe
the aggregateofall individual profiles.
Dose-response modeling for noncancer effects generates a
needfordetailedconcentrationdataasopposedtoaveragecon-
centrations. Ideally, infonnationthatshouldbeincluded incol-
umn Carepeakand average concentrations (either from mea-
surementormodelestimation)and, ifpossible, aconcentration
profile.
Averages may also prove useful, but the selection ofthe ap-
propriate averaging timecanbecritical to thecharacterization
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FIGURE 2. Concentration decay profiles. From Tichenor (4).
of health effects. For example, peak concentrations may be
reported in various time increments such as hourly averages,
15-min averages, or 8-hr averages, each having different as-
sociated health effects. Averages may also prove useful in defin-
ing exposures associated with certain activities orevents allow-
ing total exposure to be calculated on the basis of number of
events.
Exposure Duraion/Setting. Defining microenvironments,
the time individuals spend ineachmicroenvironment, andthe
activities theyareengagedinareimportantfactors fordetermin-
ingtheindividual'sexposureandtheassociatednoncancereffects
(columnDofFigure 1). Thetimingofanexposureis important
whenconcentrations arevariableovertime, as inthedecaypro-
file ofoff-gassing from new building materials. Coupled with
variableconcentrations (e.g., thoseundergoingadecayprofile)
areintermittentexposures as individuals movefromonemicro-
environment toanother. Inthese instances, the averageconcen-
tration is inadequate tocalculate total exposure. Therefore, ac-
tual exposures withindifferentmicroenvironments mustbe in-
tegrated to obtain a realistic overall exposure to then calculate
cumulativedose.
Activities are important to define or identify all relevant ex-
posures, whichmayproveimportantinaddressingmixturesand
synergisms. Itisconceivablethatseemingly unrelatedactivities
mayactually beresponsiblefortheonsetofanadversehealthef-
fect. Oneactivity may resultinexposuretoacompoundthatin-
creases individual susceptibility toacompoundassociatedwith
alateractivity. Time-seriesanalysistechniquesmayproveuseful
to address this by providing information on temporal distribu-
tions and correlating symptoms, exposure, and environmental
parameters (5).
Informationpresented incolumnDwouldincludequantitative
descriptorsofanyrelevanttime-activitypatternsincludingdura-
tionandtimeofoccurrenceforanyexposure. Informationwould
alsobeincludedfromotherexposuresoractivities toaccountfor
synergisms or sensitivities.
Exrposure Patern. Exposure is represented as not only an
overall averagevaluebutseveralrelevantvalues. Cumulativeex-
posure and peak exposures (possibly over several averaging
times) are recorded in column E of Figure 1 for each of the
pollutants. Theseexposureestimates maybederivedfromdirect
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monitoringdataorthroughindirectmethodssuchasintegrating
time-activity pattern data with pollutant concentrations in the
various microenvironments. Peak exposures are important for
comparisontothresholdvaluesandcertaindose-response func-
tions. Also, the timing ofexposures with respect to each other
may beanimportantaspectoftheexposurepatternwhenoneis
concerned with sensitization.
Dose-Response Assessment
Dose-response assessments (columns F-HofFigure 1) for
noncarcinogens havetypically focusedontheidentificationofa
thresholdbelowwhichnoadversehealtheffectsareobservedand
the derivation ofexposure levels thatare considered to protect
humanhealthbasedonthesethresholds. Littleattentionhasbeen
directedtoderivingdose-responserelationshipsdueprimarily
tothecomplexity oftheserelationships, includingtheneedtoad-
dressmultipleendpoints, multipleorgans, andvaryingdegrees
ofseverity (6).
Dose Assessment
Noncancer effects are organ specific, which may require
greater emphasis on pharmacokinetic modeling and relevant
conversion factors (columnFofFigure 1) tocalculate systemic
doseordelivereddosetospecifictargetorgans. Doseispresented
incolumn GofFigure 1, calculated asorganburdenorasatotal
body dose, and presented for several time periods; as peak,
cumulative, and/or average associated with a given activity.
Biomarkers, ifavailable, canalsobeusedtoestimateactualdose,
reducing the need for detailed exposure profiles. Biomarkers
provide noinformation onexposurepatternsandsourcesofex-
posure, except for a small number ofsources such as environ-
mental tobacco smoke.
Information presented in column F would include relevant
conversionfactors, includingpharmacokineticfactors. Informa-
tionpresentedincolumnGwouldincludepeak,cumulative, and
average dose, and, ifpossible, peak, cumulative and average
organburden. This information wouldbepresented foreachof
the pollutants being evaluated.
Dose-Response Factors
Noncancereffectsinvolvemultipletargetorgans, eachhaving
itsowndose-responserelationshipandrangeofeffectsofvarying
degrees ofseverity for each pollutant. Ideally, these multiple
dose-response factors could be represented in column H of
Figure 1. Additionally, indoorairproblems arecharacterizedby
multiplecompounds, eachofwhichwouldhavetheirowndose-
response functionsandmaypredictarangeofseverityofeffects
(6).
Toxicological data can typically be divided into three cate-
gories,quantal,graded, andcontinuous(7-9). Quantaldataex-
pressincidenceandaregenerallyexpressedintermsofnumbers
ofindividualsaffectedasafunctionofdose. Gradeddata,though
notascommonlyused, areatypeofquantaldatabutalsoinclude
judgmentormeasureofseverityofadverseeffectsasafunction
ofdose(7). Forexample,gradeddatamaybeexpressedinterms
ofidentifyingpathologies (e.g., fattyinfiltration inlivercellsto
liver necrosis). Continuous data represent the magnitude or
intensity ofa response within an individual and measures the
change in some value ofa biological indicator as a function of
dose. All types ofdata can be fit into a dose-response model,
though the actual models would differ (8). Therefore, the
characterizationoftheriskisdependentonwhichtypeofdatais
used. The framework is flexible enough to accommodate all
threetypesofdose-responsedataandtheirsubsequentmodels.
Anotherelementuniquetononcancereffectsistheconceptof
thresholds for adverse effects. While there is still substantial
debate as to what effect should be the basis for defining a
threshold(i.e.,changeinbiologicalindicatororclinicaleffect),
theexistenceofthresholds isnotcontested. Thesethresholdsdif-
fer according to the organ and effect studied. The framework
representsthesethresholdseitheraloneorasthebenchmarkfor
thedose-response relationship. Thethresholds reported incol-
umnHcanbemorespecificthanthecommonlyusedprotective
concentrations, which are based on threshold measurements
suchasacceptabledailyintakesorreferencedoses(9). TheRfD
is an estimate (within an order ofmagnitude) ofthe daily ex-
posuretothehumanpopulation(includingsensitivesubpopula-
tions)thatislikelytobewithoutappreciableriskofdeleterious
effectduringalifetime(10). Bycontrast, thethresholdsusedas
response factors could be effect specific and may also be time
dependent (e.g., shortterm, chronic, etc.).
Theuseofmathematicaldose-responsemodelsfornoncancer
effects is not common, though such methods do exist. The
methodsproposedbyDoursonetal. (7)andCrump(8)maybe
applied toestimate specificeffects atgivenconcentrations and
todevelopthe "dose-response" thresholdsdiscussedabove. Ad-
ditionally, somemethodofassessingmixtures, consideringboth
additivity andinteractions, isalsoneeded. A "mixture" dose-
responsefactor, shoulditprovepossible, maybeappliedincol-
umnHofthe framework.
Ideally, information presented in column H would include
knownthresholds asafunctionofdurationofexposure. This is
likelytobeinamatrixformat. Dose-responsefactorswouldalso
bepresentedformultipleorgansandmultipleeffects. Thesefac-
tors wouldbepresented foreachofpollutantsbeingevaluated.
Should methods bedeveloped, dose-response factors for mix-
tures or factors for adding effects from individual compounds
would also bepresented in column H.
Application to an Example Complex
Mixture
Theconceptsandissuespresentedaboverepresenttheidealin-
formation and data needs to conduct a thorough risk charac-
terizationofnoncancerhealtheffects. However, typically,thisin-
formation is not available, nor are the dose-response factors
availableoracceptedfornoncancereffects. Moretypically, risk
assessments are simplifieddue todatalimitations. The frame-
work will be applied to an example complex mixture to
demonstrate its usefulness and to testeach oftheconcepts and
issuesdiscussed above forarealproblem.
Table 1 presents an example complex mixture of VOCs
associated with a problem building. Employees experienced
increased healthcomplaints afterbuilding renovations and, in
particular, theinstallationofcertainbuildingmaterials. Efforts
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TIble 1. Volatile organics found in example complex mixture.
Compound Concentration, ppba
Toluene 13.0-22.0
Ethylbenzene 3.7- 4.6
Xylene 4.7- 8.6
Cumene 4.1- 6.9
4-Phenylcyclohexene 70.7b
Dichlorobenzene 18.0-68.0
Formaldehyde 61.OC
Acetaldehyde 15.Oc
Acetone 55.0C
aRange of concentrations represent the values from gas chromatography/
flame ionizationdetector (GC/FID) and gas chromatography/mass spectrometry
(GC/MS). Measurements made on new stored materials and are assumed to
represent the maximum exposure levels. From Burchette and Singhvi (17).
b4-PCH concentration from GC/FID, presence confirmed but no concentra-
tion quantified on GC/MS.
cPredicted concentrations at 0.1 air changes per hour due to other building
materials (officepartitions) using amodeldevelopedbytheEPA, AirandEnergy
Engineering Laboratory (AEERL) in Research Triangle Park. From Tichenor
(18).
have been made to characterize the exposure of the affected
workers. Sampling the workenvironment as well as the emis-
sions frombuildingmaterials confirmed whatis atypical indoor
airproblem, consistingofamixtureofmultiplecompounds. The
first seven compounds listed in Table 1 were the major com-
ponents identified in measurements taken from newmaterial of
the samebatch stored within awarehouse. Asoff-gassing emis-
sions from newproducts tendtodecay overtime, these measure-
ment values are assumed to represent the maximum exposure
levels. Thesecompounds will be furtherevaluated andused in
the characterization of noncancer risks. In addition, formal-
dehyde, acetaldehyde, andacetonehavebeenidentified asmajor
constituents inotherbuildingmaterials used intherenovation,
andconcentrations representestimated concentrations predicted
by a model for worst-case building ventilation conditions.
Identification ofPossible Health Effects
The initial efforts addressing health effects focused on a
reviewoftheTOXNETdatabase forthecompounds identified
in Table 1. Searches were made for each ofthe 10compounds
in the following fields: human toxicity excerpts; populations at
special risk; absorption, distribution and excretion; meta-
bolism/metabolites; biological half-life; mechanisms ofaction;
interactions; andthresholdlimitvalues(TLVs). Thereportedef-
fects havebeen summarized and arepresented inTable 2. On-
ly observed humanhealtheffects were recorded tosimplify the
initial phase and to avoid introducing uncertainties associated
with interspecies extrapolation.
Theinformationpresented inthematrix is notexhaustive, but
isillustrativeofthetypesofhealtheffectsreported. Mostofthe
information inTOXNETis fromoccupational exposures at con-
centrations much higher than that associated with indoor air
pollutants. These effects or symptoms are not necessarily ex-
pectedwith any exposureto agivencompound, butonly indicate
the rangeofpossibleeffects. Itshouldalsobekeptinmindthat
other effects may be possible, but have not been identified or,
ifthey have been identified, not reported in TOXNET.
Thisapproachislimitedbybothreportedinformationandthe
extent to which a compound has been studied. For example,
comparing formaldehyde and 4-phenylcyclohexene (4-PCH),
onewouldgettheimpressionthatformaldehydeisanimportant
componentandmajorcontributortohealthimpactsfromindoor
air, whereas4-PCHcontributesnothingtotheseeffects. While
thismaybetrue, studybiasmaybeamoreaccurateexplanation.
Formaldehyde isoneofthemoststudiedcompounds, havingan
extensivedatabase, whereasnoinformationis reported inTOX-
NETon4-PCHand, infact,onlyrecentlyhaveanytoxicological
tests (animal bioassays) been carried out on 4-PCH.
Comparison with Common Thresholds (Health
Effects Benchmarks)
Thenextlevelofsophistication istointroducequantitativeor
elementsofthresholdsdose-response. Acommonlyrecognized
threshold is that of TLVs for use in an occupational setting.
Although there are many objections to applying TLVs to the
general public exposure setting, TLVs have been used by a
numberofstatestoestablishairtoxicsstandards. TLVs should
notbeused indiscriminately as aprotective level forall indoor
exposures, but can be used for a gross appraisal of possible
healtheffects. Anothercommonthresholdistheodorthreshold.
Odors havebeen hypothesized to play an important role in in-
doorairproblemsbybringing attention ofthe individual toany
symptoms, linking the odor (source) with any symptoms, or
leading to symptoms directly (11). TLVs and odor thresholds
werefoundforallcompoundsexcept4-PCH, forwhichonlyan
odorthreshold has beenestimated, and arepresented in Table
3. Observedconcentrations were several orders ofmagnitude
lowerthantheirrespectiveTLVs, andodorthresholdswereex-
ceeded forthree compounds (acetaldehyde, formaldehyde, and
4-PCH).
Theoretically, comparisonofobservedconcentrations to any
existing thresholds can be made for individual compounds.
Thesethresholds canbeforawide rangeofeffects. However,
there are few data available on thresholds for health effects at
low concentrations (in acontrolled setting) which represents a
severe limitation to this approach.
Mixture Index Values
Allofthepreviousapproacheshavefocusedontheindividual
compounds andtheirrespectivehealtheffects. Itisdesirableto
develop somemethodofassessingthemixtureasawholerather
than the sum ofits individual components (13). The EPA has
recommended several approaches in their Complex Mixture
RiskAssessmentGuidelines (14). Basedontheapproaches sug-
gested in theguidelines as well as a review ofthe literature of
noncancerriskassessment, aproposedapproachofusingamix-
tureindexvaluehasbeenapplied. Thereareseveraloptionsfor
thesemixtureindexvalues, whichinclude: hazardindex, margin
ofexposure, additivity (with relativepotency), responseaddi-
tion, comparativepotency andtoxicityequivalentfactors, total
organics(orbychemicalclass), indicatorcompoundconcentra-
tions, interactions, and tiered approach.
Thehazardindex, marginofexposure, andadditivity assume
additivityofeffects, andinvolvethesummationofhealtheffects
forindividualcompounds. Comparativepotency isdifferent in
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Table 2. Summary ofreported effects ofvarious indoor air pollutants.
Compounda
Effect AcA ACE CUM DCB EtB FOR STY TOL XYL 4-PCH
Eyes
Irritation X X X X X X X X
Irritated mucous membranes X X X
Conjunctivitis X X X X
Lacrimation X X X
Diplopia (double vision) X
Photophobia X
Nose
Irritation X X X X X X
Irritated mucous membrane X X X X
Runny nose X
Respiratory
Irritation X X X X X X
Pharyngitis X X
Throat irritation X X X X
Bronchitis X X X X
Coughing X X
Shortness ofbreath X
Asthmatic reaction X
Pulmonary edema X X
Central nervous system
Tinnitis X
Headache X X X
Dizziness X X X X
Depression X
Fatigue X
Confusion X X X
Drowsiness X X
Vertigo X X X X
Slowed reaction time X X
Intoxication: euphoria X
Exhilaration X X X
Boastful, talkative X
Incoordination (ataxia) X X X X
Anesthesia X X
Edema X
Weakness X X
Skin
Erythema, irritation X X
Dermatitis X X X
Blood
Leukopenia X X
Leukocytosis X X
Macrocytosis X
Reduced erythrocytes X
Liver injury X
Miscellaneous
Gastritis X
Nausea and vomiting X
Dysphagia (difficulty swallowing) X
Menstrual disorders X X
Loss ofweight X
WAcA, acetaldehyde; ACE, acetone; CUM, cumene (isopropylbenzene); DCB, dichlorobenzene; EtB, ethylbenzene; FOR, formaldehyde; STY, styrene; TOL,
toluene; XYL, xylene; 4-PCH, 4-phenylcyclohexene. Thistablesumnunarizes thosehuman healtheffects reportedin1DXNETforthesecompounds. Absenceofsymp-
toms does not inherently meanthatthesedo notexist foragivencompound, onlythatthey were notreported inTOXNET. Differences inthe numberofsymptoms
reported maybeduetothedifferences inavailable informationbecause somecompounds may havebeenextensively studied, whileothershave notbeenstudiedat
all in the human population (e.g., 4-PCH).
thatthetoxicityofthemixtureisassesseddirectly withoutatten- tionoftotalhealtheffects. Interactionsareaformalapproach for
tion to individual components and is based on the assumption addressingthephysiological effectsindividual compoundshave
thatbioassays areapplicable tohumanhealth prediction. Mix- on one another, either synergistically or antagonistically. The
tures arecomparedonthebasisofbioassay results(15). Thetotal tiered approach integrates elements ofprevious approaches. It
chemical class approach assumes little difference in relative would have a ceiling threshold to protect against a severe
potencies between compounds with the same chemical (clinical) effectandadose-responsecomponenttoestimate the
characteristics. Theindicatorcompoundapproachassumesthat distribution of less severe effects at concentrations below the
asinglecompound is indicative orresponsible foralarge frac- threshold.
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lIable3. Comparison ofobserved concentrations totwoexamplethresholds.2
Maximum observed
Compound concentration, ppm TLV, ppm Odorthreshold, ppmb
Acetaldehyde 0.015 100 0.00011-2.23
Acetone 0.055 750 19.675-668
Cumene (isopropylbenzene) 0.0069 50 0.0008-1.3
Dichlorobenzene 0.068 75 2.0-30
Ethylbenzene 0.0046 100 2.0-200
Formaldehyde 0.061 1 0.05-49
Styrene 0.033 500 0.047-200
Toluene 0.022 100 2.14-70
Xylene 0.0086 100 0.08-40
4-Phenylcyclohexene 0.072 - 0.001-0.01C
aConclusions: observed concentrations < TLVs for all compounds; observed concentrations > three odorthresholds.
bFrom Ruth (12).
cFrom unpublished reports.
These mixture indexvaluesmayproveusefulaseitherabsolute above their individual observed thresholds (NOAEL).
or relative predictors ofrisk (or effects). To validate their use- Foramixture, theMOEissumoftheMOE1 fortheindividual
fulness, efforts mustbeundertaken tocorrelatethevariousindex constituents for a given target organ. Individual MOE1 values
valueswithcontrolledhumanchamberstudiesatlowexposures, shouldonlybesummedforthesametargetorgansystem. Three
with bioassay data, or with epidemiological data. Once a mix- ofthe five compounds having inhalation RfDs have identified
ture index value is selected, it can then be used to rank various NOAELs forthecentral nervous system. Therefore, amixture
mixtures fortoxiceffectsandallowmanufacturers toassessthe MOE for the central nervous system (MOECNs) can be cal-
need forandeffectiveness ofmitigation measures. culated. TheMOECNSwascalculatedas560. Thisisinterpreted
Two mixture index valueapproaches havebeenappliedtothe as indicating that the exposures are about 560 times below the
example complex mixture, the hazard index and margin ofex- "threshold value forthemixture."
posureapproaches. Thesehavebeenapplied totheexamplemix- Thehazardindexapproachisthemostcommonmethodused
tureforthoseconstituentswithEPA-verifiedinhalationRfDsand fornoncancereffectsfrommixturesandissuggestedintheEPA
are summarized inTable4. Bothofthesemethodsarerelatedto Guidelines on Complex Mixtures (12). It is the accepted prac-
theNOAELbasedeitheronanimal studiesorhumandata. The ticeinSuperfundriskassessments. Thehazardindex(HI) isthe
margin of exposure for each individual substance (MOE1) is sum ofthe hazard index for individuals compounds (HI1) for a
defined astheratiooftheNOAELofacompoundtotheexposure given targetorgan. Thehazardindex forindividualcompounds
for that substance (16). The MOE1 is not a direct measure of is the ratio ofexposure ofa compound to the RfD. The RfD is
risk; astheMOE, approachesthevalueof1, thelevelofconcern definedbydividingtheNOAELforthemostsensitivespeciesby
forpossibleeffects is increased. Itisinterpreted astheextentto anuncertaintyandmodifyingfactor, whichcompensatesfordose
which humanexposures arebelowtheobserved NOAELinthe extrapolation, inter-andintraspeciesvariability, studydesign,
study species. Five compounds of the example mixture had andavailable data. Similar tothe MOEapproach, as HI1 values
verified inhalation RfDs. MOE1 valueshavebeencalculatedfor approach 1, the level ofconcern forpossible health effects in-
thesecompounds andarepresentedinTable4. Fortheexample creases. Values exceeding 1 indicate thatthe RfD has been ex-
complex mixture, the MOE1 values are all within an order of ceeded. The HI, values calculated for those five compounds
magnitude of each other and are several orders ofmagnitude having verified inhalation RfDs vary from 0.032 for toluene to
lable 4. Index approach examples.
Observed
concentra- NOAEL, Study RfD
Compound (i) tion, ppb ppb species Organ/effect MOE,a UF mg/m3 ppb confidenceb HIiC
Acetaldehyde 15.0 66,000 Rats Histopathological 4400 3,000 0.04 22 M/L/L 0.682
(LOAEL) changes in respiratory
tract
Cumene 5.5 18,700 Rats CNS, nasal irritation 3400 10,000 0.009 1.8 L/L/L 3.056
(LOAEL)
1,4-Dichlorobenzene 43.0 11,210 Rats Urinary protein output 260 100 0.7 115 H/M/M 0.374
increased liver,
kidney weights
Toluene 17.0 40,000 Human CNS (dizz, headache) 2350 100 2.0 533 M/M/M 0.032
eye, nose irritation
Xylene 6.6 6,200 Human CNS, irritation 940 100 0.3 69 M/M/M 0.096
aMargin of exposure (MOE): MOE = observed concentration/NOAEL; e.g., MOECNS = [1/E(1/MOEj)] = [1/MOECUM + l/MOEFvL + I/MOExyj -' =
[(0.000294) + (0.000425) + (0.00106)] = 560 times below the observed threshold level.
bConfidence: study/database/RfD. H, high; M, medium; L, low.
'Hazard index (HI): HIi = observedconcentration/RfD (where RfD =NOAEL/UF); e.g.,HICNS= EHI =HlCuM +HI.TL + HIxYL = 3.056 + 0.032 + 0.096.
HICNs = 3.184 > > 1.
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3.056 forcumene. This is interpretedas indicating thattoluene
exposure isatabout3% oftheRfD, whilecumeneexposuresare
more than three times the RfD level.
Cumene wouldappeartobetargetedasthe major toxic com-
ponent inthemixtureusingthis method. However, care should
betaken in interpretingtheRfD, as itisnota single numberes-
timateofthreshold orrisk. Therearemultiplecomponentstoan
RfD. Thesinglevalue foranRfDmustbeconsidered inlightof
theuncertainty factorusedinitscalculation andinitsconfidence
designation. Theconfidence designationconsists ofthreecom-
ponents and indicates confidence in study design (in which the
NOAEL was identified), in the overall database, and in the
overall RfD. Itshouldbenotedthatthetwocompounds withthe
highestHIj, cumeneandacetaldehyde, arealsothosecompounds
with the greatest uncertainty factors and the lowest confidence
designations. Therefore, in reviewing the mixture and relative
importance ofeach constituent and in the overall index value,
these qualitative aspects ofuncertainty should beconsidered.
Anoverall mixture HI wascalculated forthecentral nervous
system(HICNS). Thevalueof3.184 indicatesthattheexposureis
morethanthreetimestheestimated "mixtureRfD" forCNSef-
fects. However, it should be noted that the cumene, which, as
described above, has the highest uncertainty and lowest con-
fidencedesignation, contributes about96% totheoverall index
value. Therefore, thisuncertainty shouldbeincludedinany in-
terpretation of this index value. Although there is significant
uncertainty intheRfD, thisisauseful method foridentifyingand
predicting some health (CNS) effects forthe example mixture.
Conclusions
The noncancer risk characterization framework has shown
promise. The initial efforts discussedherearepreliminary and
should lead to further development ofnoncancer risk charac-
terization methodologies. The framework has proven to be a
useful tool for displaying the complexity of noncancer risk
characterization, integrating information for the various com-
ponentsofariskassessmentfromseveral sources, andevaluating
dataand information.
The framework (as depicted in Figure 1) lists the key issues
specific to noncancer riskcharacterization. Itdisplays thedata
and information needs toproperly address noncancerhealthef-
fects. Noncancerriskcharacterizationdiffers fromcancerrisks
primarily in the fact that noncancer health effects are multi-
dimensional, with a wide range of health effects of varying
severityaffectingmultipleorgans. ColumnsI-Joftheframework
(Fig. 1)display-thedesiredendpointsinnoncancerhealtheffects
characterization andhowtheeffects shouldcharacterized. Col-
umns C-Hofthe framework(Fig. 1)showthedataandinforma-
tion needs tocarry out such acharacterization.
The framework provides a formal mechanism to integrate
information from several sources relating to exposure, dose
response, and health effects. This was demonstrated in the
application totheexamplecomplex mixture inwhichtheframe-
work facilitated the organization of data for source charac-
terization, forconstituents andtheir respective concentrations
(Table 1), corresponding to columns B and C(Fig. 1), and for
individual healtheffectsreported intheexposedpopulation and
intheliterature(e.g., Table4), corresponding tocolumnsI-Kof
Figure 1.
Following fromtheintegration ofinformation, theframework
isalso useful inevaluating theexistence andqualityofdataand
information. Related totheexamplecomplex mixture, existing
data were available forcolumns Band C, pollutant source and
concentration, and forcolumns I-K, individual health effects,
exposedpopulation, andpopulationhealtheffects. Alldataare
considered tobepreliminary andlimited. Pollutant concentra-
tionsrepresentamaximumvalueoff-gassingfromthesourceand
donotrepresentactualexposures. Healtheffects intheexposed
populationarelimitedtoself-reportedsymptomsofananecdotal
nature with few dataon incidence in theoverall population.
Several majordatagapsareapparentfromreviewingavailable
information. There isalackofdataonexposureduration/setting
(columnD), exposure (columnE), doseconversion factors (col-
umnF), dose-response factors (columnH). Maximumconcen-
trations arepresented withlittle informationontheactual con-
centrations of exposure and time-activity patterns for the
exposedpopulation, whichlimitsthecalculationofexposureand
dose. Also, therearelimiteddataonnoncancer dose-response
factors, thoughthis is anarea receiving significantattention.
Preliminaryefforts indeveloping andapplyingtheframework
have proven successful, though there is still a need for further
refinement. Theframeworkdisplaysthecomplexity ofthe risk
characterizationprocessandthevarietyofdataneeds. Itisuseful
in defining research needs and strategies (as in identifying the
datagapsabove)toobtainnecessarydata. Theframeworkispar-
ticularly useful in pointing out data needs in a variety ofdis-
ciplinesandhowthesedataneedtobeintegratedtoobtainacom-
pleteriskcharacterization. Suchanapproachcanhelptodevelop
researchstrategiesthataremultidisciplinary andaddressthefull
range ofissues relating to noncancer riskcharacterization.
This work wassponsoredbytheU.S. EPAEnvironmental Criteriaand Assess-
ment Office, Research Triangle Park, NC, and the U.S. EPA Office ofToxic
SubstancesandOfficeofPolicyAnalysis, Washington, DC. Thisworkwasfunded
underEPAcontractno. CR815509-01-0. Viewsexpressedarethoseoftheauthors
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